AKTS
US EQUITY
Health Care
Biotechnology & Medical
CIK: 2035832
Aktis Oncology, Inc. (AKTS) Quant Factor Diagnostic & Fair Value Model
Aktis Oncology, Inc. (Ticker: AKTS) is listed in the Health Care sector (Biotechnology & Medical). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$15.73
-6.15%
Latest Close (2026-10-23)
Market Cap: $874.89M
P/E Ratio: -
Momentum Strength
3M / 12M
-35.03%
1M: -19.87%
12M: 0.00%
Quality (ROE)
Point-in-Time
-
Trailing Return on Equity
Technical Trend
RSI 14
30.9
SMA50: $21.41
SMA200: $23.27
Valuation Multiplier
Trailing
-
Pre-Profit / Negative TTM
📊
Valuation & Multi-Factor Diagnostic
Pre-Profit / Negative TTM
AKTS has negative or near-zero trailing GAAP earnings over the trailing twelve months.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线整理 (MA20/50)
Piotroski F-Score: 0/9 (Under Pressure or Early Stage Growth)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 2035832 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| No point-in-time filings synced yet. Automated batch scheduler will align CIK: 2035832 | ||||||
💡 Methodology & Frequently Asked Questions
Key reference details regarding Aktis Oncology, Inc. (AKTS) valuation multiples, momentum factors, and point-in-time filing conventions.
How should AKTS's current valuation multiple be interpreted? ↓
AKTS trades at a trailing P/E of -x within the Health Care sector (pre-profit / negative ttm). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are AKTS's key momentum and technical factor indicators? ↓
As of the latest close, AKTS shows a 1-month return of -19.87%, 3-month return of -35.03%, and 12-month return of 0.00%, with a 14-day RSI of 30.9. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for AKTS? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can AKTS be incorporated into systematic factor models? ↓
AKTS can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.